Clinical Value and Cost-effectiveness of a Personalized Prevention Program (PPP) in Patients With High Risk Stable CHD

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(26 sites)

Finland

Helsinki University Hospital, Helsinki

Mehiläinen, Helsinki

Kuopio University Hospital, Kuopio

Oulu University Hospital, Oulu

Germany

Klinik am See, Berlin

CCV-MVZ, Frankfurt

Heidelberg University, Mannheim

Technise Universität Munchen, München

Herzklinik Ulm, Ulm

Greece

Hellenic Red Cross Hospital, Athens

Konstantopoulio Hospital, Athens

Sismanoglion Hospital, Athens

The Biomedical Research Foundation of the Academy Athens, Athens

Italy

University Hospital Genova, Genova

Multi Medica, Care and Research Institute, Milan

Casilino Hospital Rome, Rome

University Hospital Turin, Turin

Poland

University of Bialystok, Bialystok

Medical University of Silesia, Katowice

Jagellonian University Medical College, Krakow

University of Lublin, Lublin

Nicolaus Copernicus University, Toruniak

National Institute of Cardiology, Warsaw

Portugal

Hospital de Santa Cruz-CHLO, Carnaxide

Hospital do Espirito Santo, Lisbon

Hospital Santa Maria-CHULN/FMUL, Lisbon